PMVP Valuation Metrics
FCF$-73.58M
FCF Growth Rate—
EPS Growth (CAGR)—
WACC10.00%
PMV Pharmaceuticals Inc
Exchange: NASDAQSector: HealthcareIndustry: Biotechnology
PMV Pharmaceuticals Inc
Did you know?
Capital expenditures decreased by 100% from FY24 to FY25.
Current Price
$1.43
+1.79%Profile
Valuation (TTM)
Market Cap$74.50M
P/E-0.96
EV—
P/B0.71
Shares Out52.28M
P/Sales—
Revenue$0.00
EV/EBITDA—
PMV Pharmaceuticals Inc (PMVP) Valuation
Fair Value Models
Graham Number, PEG-based, and Earnings-based models
View Fair Value →PMVP Valuation & Fair Value Analysis
PMV Pharmaceuticals Inc (PMVP) valuation analysis using multiple fair value methodologies. GoodMoat calculates a blended fair value target using discounted cash flow (DCF) analysis, the Graham Number, and earnings-based valuation models.
The price-to-earnings (P/E) ratio is -0.96. Price-to-book ratio is 0.71. PEG ratio is 0.04.
GoodMoat's valuation models include the Graham Number (based on EPS and book value), an earnings-based model (discounted future EPS), and a PEG-adjusted valuation. The three models are averaged to produce a blended fair value estimate. Use these tools alongside the DCF calculator and reverse DCF to form a comprehensive view of PMV Pharmaceuticals Inc's intrinsic value.